Aortech, the heart valve developer formerly based in Lanarkshire, has signed a licence deal with a US company that should underpin its future after being saved from collapse last year.
Biomerics of Salt Lake City will manufacture and distribute its patented Elast-Eon and ECSil materials and supply the polymer requirements of AorTech's current licensees.
It follows AorTech's exit from manufacturing and its adoption of a new strategy to "exploit the value of the company's IP, patents and knowhow without incurring the further substantial expenditure required to maintain and develop manufacturing facilities, product development expertise and sales and marketing resources".
Chairman Bill Brown, the former Edinburgh-based fund manager, said: "This is the most important deal AorTech has done."
He said AorTech's size and scale had made it impossible to get its material into major medical device companies, who were taking it "despite AorTech".
The company was rescued when emergency bondholders earned a 100% return and a 15% stake in the company for enabling AorTech to defend itself in US litigation last year.
Mr Brown said: "It is now a business that if everything goes to plan will take the material into new areas....we have got the potential to make more margin from any sales without having any cost, and are close to being a pure IP company." He said the heart valve project had potential "at some point - it has been one piece at a time".
Frank Maguire, chief executive, said: "This relationship with Biomerics provides for large volume manufacturing economies of scale.... a deep pool of talented application engineering resources facilitating new business development, and access to new customers and markets for AorTech polymers."
Aortech shares, which had climbed to 370p in February 2012 before crashing to 55p in October, rose 4p to 81.5p, valuing AorTech at just under £4m.
Why are you making commenting on The Herald only available to subscribers?
It should have been a safe space for informed debate, somewhere for readers to discuss issues around the biggest stories of the day, but all too often the below the line comments on most websites have become bogged down by off-topic discussions and abuse.
heraldscotland.com is tackling this problem by allowing only subscribers to comment.
We are doing this to improve the experience for our loyal readers and we believe it will reduce the ability of trolls and troublemakers, who occasionally find their way onto our site, to abuse our journalists and readers. We also hope it will help the comments section fulfil its promise as a part of Scotland's conversation with itself.
We are lucky at The Herald. We are read by an informed, educated readership who can add their knowledge and insights to our stories.
That is invaluable.
We are making the subscriber-only change to support our valued readers, who tell us they don't want the site cluttered up with irrelevant comments, untruths and abuse.
In the past, the journalist’s job was to collect and distribute information to the audience. Technology means that readers can shape a discussion. We look forward to hearing from you on heraldscotland.com
Comments & Moderation
Readers’ comments: You are personally liable for the content of any comments you upload to this website, so please act responsibly. We do not pre-moderate or monitor readers’ comments appearing on our websites, but we do post-moderate in response to complaints we receive or otherwise when a potential problem comes to our attention. You can make a complaint by using the ‘report this post’ link . We may then apply our discretion under the user terms to amend or delete comments.
Post moderation is undertaken full-time 9am-6pm on weekdays, and on a part-time basis outwith those hours.
Read the rules hereComments are closed on this article